purpose evaluate feasibility acute toxicity proton therapy deep sedation young children rhabdomyosarcomas rms patients methods NUMBER children requiring sedation admitted proton therapy paul scherrer institute psi villigen switzerland children NUMBER years age rms head trunk analyzed children enrolled multidisciplinary treatment protocol prospective standardized evaluation effects performed results children included aged years embryonal rms alveolar undifferentiated nonclassified tumor site parameningeal n NUMBER orbital n NUMBER head neck n NUMBER prostate n NUMBER children irs group iii total proton dose cge equivalent myelotoxicity exceeded grade NUMBER NUMBER conclusion proton therapy rms early children feasible tolerated prospective standardized evaluation toxicity quality life needs continued spot scanning NUMBER NUMBER NUMBER NUMBER cobalt gray rtog eortc